别名:PPP1R12A; MBS; MYPT1; Protein phosphatase 1 regulatory subunit 12A; Myosin phosphatase-targeting subunit 1; Myosin phosphatase target subunit 1; Protein phosphatase myosin-binding subunit应用:WB,IHC
反应种属:Human,Mouse,Rat,Monkey
规格:50μl/100μl
| Description |
|---|
| Key regulator of protein phosphatase 1C (PPP1C). Mediates binding to myosin. As part of the PPP1C complex, involved in dephosphorylation of PLK1. Capable of inhibiting HIF1AN-dependent suppression of HIF1A activity. |
| Specification | |
|---|---|
| Aliases | PPP1R12A; MBS; MYPT1; Protein phosphatase 1 regulatory subunit 12A; Myosin phosphatase-targeting subunit 1; Myosin phosphatase target subunit 1; Protein phosphatase myosin-binding subunit |
| Entrez GeneID | 4659 |
| Swissprot | O14974 |
| WB Predicted band size | Calculated MW: 115 kDa; Observed MW: 140 kDa |
| Host/Isotype | Rabbit IgG |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human,Mouse,Rat,Monkey |
| Immunogen | The antiserum was produced against synthesized peptide derived from human MYPT1. AA range:661-710 |
| Formulation | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, pH 7.3. |
| Application | |
|---|---|
| WB | 1/500-1/1000 |
| IHC | 1/50-1/100 |
| ELISA | 1/10000 |
![]() |
Western blot analysis of Myosin Phosphatase in various lysates using Myosin Phosphatase antibody. |
![]() |
Western blot analysis of Myosin Phosphatase in 293T lysates using MYPT1 antibody. |
![]() |
Western blot analysis of Myosin Phosphatase in COS7 lysates using Myosin Phosphatase antibody.The lane on the right is blocked with the synthesized peptide. |
![]() |
Immunohistochemistry analysis of paraffin-embedded Human breast carcinoma tissue using MYPT1 antibody. High-pressure and temperature Sodium Citrate pH 6.0 was used for antigen retrieval. Sample with blocking peptide on the right. |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
中文




发表回复